» Authors » Dave Allen

Dave Allen

Explore the profile of Dave Allen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 811
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Allen D
Drug Discov Today . 2016 May; 21(5):704-6. PMID: 27131748
No abstract available.
12.
Knight M, Pierce M, Allen D, Kurinczuk J, Spark P, Roberts D, et al.
Br J Haematol . 2011 Jan; 152(4):460-8. PMID: 21210775
Fetomaternal alloimmune thrombocytopenia (FMAIT) is the most common cause of severe neonatal thrombocytopenia in otherwise well, term infants. First pregnancies are often severely affected. This descriptive, population-based national study was...
13.
Lucas G, Culliford S, Green F, Sidra G, Calvert A, Green A, et al.
Transfusion . 2009 Oct; 50(2):334-9. PMID: 19874563
Background: Patients with human platelet antigen (HPA) specific antibodies in cases of neonatal alloimmune thrombocytopenia and platelet (PLT) refractoriness derive clinical benefit from the use of HPA-selected PLTs. Study Design...
14.
Rayment R, Kooij T, Zhang W, Siebold C, Murphy M, Allen D, et al.
J Immunol . 2009 Jun; 183(1):677-86. PMID: 19535639
Maternal alloantibodies against the human platelet Ag (HPA)-1a allotype of the platelet beta(3) integrin GpIIb/IIIa can cause severe fetal or neonatal hemorrhage. Almost all anti-HPA-1a-immune mothers are homozygous for HPA-1b...
15.
Ghevaert C, Campbell K, Stafford P, Metcalfe P, Casbard A, Smith G, et al.
Transfusion . 2007 Jun; 47(7):1296-305. PMID: 17581167
Background: The antenatal management of fetomaternal alloimmune thrombocytopenia (FMAIT) due to HPA-1a antibodies remains controversial, and a test identifying pregnancies that do not require therapy would be of clinical value....
16.
Ghevaert C, Campbell K, Walton J, Smith G, Allen D, Williamson L, et al.
Transfusion . 2007 May; 47(5):901-10. PMID: 17465957
Background: Fetomaternal alloimmune thrombocytopenia (FMAIT) is the commonest cause of severe thrombocytopenia in term neonates but its management remains controversial. Study Design And Methods: A 7-year prospective observational study of...